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Available online 15 September 2016Fibroblasts from the foreskin of a 6-year-old healthy boywas used to generate induced pluripotent stem cell line
(ULEIi001-A) by lipotransfection with episomal vectors. Pluripotency and differentiation potential of the cell line
was conﬁrmed in vitro. Additionally hepatic differentiation potential of the cell line was investigated.
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Human foreskin ﬁbroblasts were reprogrammed by lipotransfection
with oriP/EBNA1 (Epstein–Barr nuclear antigen-1)-based episomal vec-
tors (Yu et al., 2009). Plasmids contain reprogramming factors OCT4,
SOX2, NANOG, KLF4, L-MYC, Lin28, shRNA-p53, and miR302/367
cluster, along with the GFP marker (System Biosciences) for efﬁcient. Giri),
. This is an open access article underpluripotency induction (Takashi et al., 2007, Yu et al., 2007, Kawamura
et al., 2009, Anokye-Danso et al., 2011). Obtained cell line ULEIi001-A
was characterised and its differentiation potential was demonstrated.
No GFP expression was observed 30 days after transfection. Obtained
iPSCs are morphologically similar to embryonic stem cells (Fig. 1A)
and express pluripotency markers: OCT4, SOX2, NANOG, SSEA4,
Claudin4 (Fig. 1B). They are able to differentiate into three germ layers
(Fig. 1C), and into hepatocyte-like cells (Fig. 1D). Furthermore, this
cell line has normal karyotype (Fig. 1E).
Materials and methods
Fibroblasts isolation
The foreskin samples were obtained from the private clinic (Pediat-
ric and Ambulatory Surgery, Elster Passage, Zschochersche Straße 48,
04229 Leipzig). The donor was a healthy 6-year-old boy. The tissue
was removed according to conventional aseptic techniques. The dissect-
ed skin was washed and disinfected. After overnight incubation in
Diaspase II (Sigma-Aldrich) 4 °C, epidermis was removed. The skin
pieces were plated on culture dish and explant ﬁbroblast cultures
were maintained at 37 °C in 5% CO2 in Dulbecco's Modiﬁed Eagle's Me-
dium (DMEM, LifeTechnologies) low glucose, supplemented with 20%
fetal bovine serum (FBS, LifeTechnologies) and penicillin (100 U/mL)-
streptomycin (100 μg/mL).
Reprogramming of ﬁbroblasts to iPSc
The foreskin ﬁbroblasts were thawed and expanded in DMEM
medium (LifeTechnologies) low glucose with 10% ESC qualiﬁed FBS
(Life Technologies). The cells were transfectedwith episomal vectors
containing reprogramming factors: human Oct4, Sox2, Klf4, L-myc,
Lin28, shRNA-p53, miR302/367 cluster and GFP (System Biosciences).
For transfections, Lipofectamine 3000 (Life Technologies) was used
according to manufacturer's protocol. The cells in passage number 4
were seeded into Geltrex coated 6-well plate (Life Technologies) onethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterisation of ULEIi001-A iPS cell line. (A) Morphology of the iPSCs. (B) Immunocytochemical detection in iPSCs of the pluripotencymarkers, NANOG, OCT4, SOX2, SSEA4 and
Claudin6. (C) Differentiation potential. Immunocytochemical staining of in vitro iPSCs differentiation: Neuroﬁlament heavy (NFH), smoothmuscle actin (αSMA), alpha-fetoprotein (AFP).
(D) Hepatic differentiation of iPSCs: hepatic nuclear factor 4 alpha (HNF), albumina (ALB). (E) Karyogram of the new cell line passage number 20.
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Fig. 1 (continued).
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prepared in OptiMEM medium (Thermo Fisher Scientiﬁc) and
added dropwise to the cells. On the following day, medium was
changed and on third day second transfection was performed. Medi-
um was changed daily. Fibroblast medium was changed to Essential
8 (E8, Life Technologies) 15 days after transfection. Colonies were
picked up mechanically on day 24 and plated in separate wells on
Geltrex coated 24-well plate. After 5 days, the best iPS cell line was
chosen for future expansion. There was no GFP expression in the cells
30 days after plasmid transfection. Cells were routinely split using
Versene (LifeTechnologies) in feeder free conditions in the presence of
E8 medium.Pluripotency marker staining of hiPSCs
For immunostaining of iPSCs were ﬁxed for 15min at room temper-
ature (RT) in 4% paraformaldehyde solution Roti-Histoﬁ (Carl Roth
GmbH + Co. KG), then washed three times in PBS (LifeTechnologies),
and blocked and permeabilized for 1 h in PBS with 1% fetal bovine
serum (Sigma-aldrich) and 0,01% of saponin (Sigma-aldrich). Cells
were then incubated with primary antibodies overnight at 4 °C, rinsed
three times with PBS, and incubated with secondary antibodies for 1 h
at RT. DAPI was used as a nuclear counterstain (Thermo Scientiﬁc).
Antibodies used for characterisation of iPS cells: Nanog (Cell Signaling
4903 rabbitmonoclonal IgG), Oct4 (Cell Signaling 2840 rabbitmonoclonal
575A. Skrzypczyk et al. / Stem Cell Research 17 (2016) 572–575IgG), Sox2 (Cell Signaling 3579 rabbit monoclonal IgG), SSEA4 (Thermo
Scientiﬁc MA1-21 mouse monoclonal IGG), Claudin6 (R&D Systems
MAB3656 mouse monoclonal IGG). Alexa Flour 488 conjugated antibody
goat anti-rabbit and Alexa Fluor 633 conjugated antibody goat anti-
mouse (Thermo Scientiﬁc) were used as secondary antibodies.
In vitro spontaneous differentiation
iPSCs colonies were detached from plate using Versene
(LifeTechnologies) and suspended in Essential 6 medium
(LifeTechnologies). The cell aggregates were cultured in suspension
on low attachment Petri dishes to generate embryoid bodies. After
7 days, embryoid bodies were transferred to Geltrex-coated 6-well
plates and cultured for another 14 days. Afterwards cells were stained
(as described before) for markers for neurons (Neuroﬁlament heavy
Novus Bio NB300-135, rabbit polyclonal) and muscle cells (Alpha-
Smooth muscle actin Sigma A5228, mouse monoclonal) to show their
potential to differentiate into respectively ectoderm and mesoderm.
In vitro hepatic differentiation
For the hepatic differentiation previously described protocolwas used
with modiﬁcations (Si-Tayeb et al., 2010). Brieﬂy, endoderm induction
was initiated by RPMI1640 media containing B27 Supplements Minus
Insulin (Invitrogen), 100 ng/mL Activin A (R&D Systems), 20 ng/mL
ﬁbroblast growth factor 2 (FGF2) (R&D Systems) and 10 ng/mL bone
morphogenetic protein 4 (BMP4) (Peprotech). After 8 days of culture
dishes were moved to hypoxia (4%O2) in RPMI/B27 Supplements
(Invitrogen) medium with 20 ng/mL BMP4 and 10 ng/mL FGF2 for
5 days. Then cells were cultured in RPMI/B27 supplemented with
20 ng/mL hepatocyte growth factor (HGF, Peprotech) for additional
5 days in hypoxia. Final stage of differentiation was in normoxia in
HCM™ hepatocyte culture medium (Lonza, but omitting the EGF)
supplemented with 20 ng/mL Oncostatin M (R&D Systems) for 5 days.
Mediumwas prepared freshly and changed daily. Cells were then stained
(as described before) for markers for endoderm – Alpha Fetoprotein
(Dako A 0008, rabbit polyclonal) and hepatocytes: HNF4A (Abcamab92378, rabbit monoclonal), Albumin (R&D Systems mab14-55,
mouse monoclonal).
Karyotype analysis
Chromosomal analysis was performed after GTG-banding by Dr.
Heidrun Holland (Team Leader, Authentication, Stability, and Identity
of Cells, SIKT and Faculty of Medicine Leipzig University, Philipp-
Rosenthal Str. 55, Leipzig, Germany). Seventeen metaphases were
counted and three karyograms analysed with no evidence of numerical
or structural chromosomal aberrations.
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